Germany Anticoagulation Market - DOAC Adoption Surpassing Warfarin in Atrial Fibrillation Stroke Prevention
Market Overview The Germany anticoagulation market is transforming as direct oral anticoagulant adoption surpasses warfarin in German atrial fibrillation stroke prevention practice. The Germany Anticoagulation Market is projected to grow through 2030, driven by increasing atrial fibrillation prevalence in aging population, growing physician preference for DOACs based on clinical trial evidence,...
0 Comments 0 Shares 283 Views 0 Reviews